2.64
Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
49.54%
225.61
|
150.86 | 101.00 | 86.69 | 115.18 |
|
|
24.73%
162.32
|
130.14 | 113.58 | 89.72 | 82.14 |
| Benefits Costs and Expenses |
25.04%
162.18
|
129.70 | 112.84 | 112.48 | 109.35 |
| Costs And Expenses |
25.04%
162.18
|
129.70 | 112.84 | 112.48 | 109.35 |
| Operating Income/Loss |
205.35%
63.29
|
20.73 | -12.58 | -26.75 | 6.242 |
| Nonoperating Income/Loss |
68.13%
0.138
|
0.433 | 0.742 | 0.963 | -0.419 |
| Income/Loss From Continuing Operations Before Tax |
199.75%
63.43
|
21.16 | -11.83 | -25.78 | 5.823 |
| Income Tax Expense/Benefit, Deferred |
507.32%
15.63
|
-3.837 | -1.026 | -1.266 | -2.198 |
| Income Tax Expense/Benefit |
4,947%
19.73
|
-0.407 | -2.442 | -6.94 | -6.508 |
| Income/Loss From Continuing Operations After Tax |
102.62%
43.70
|
21.57 | -9.392 | -18.84 | 12.33 |
|
|
102.62%
43.70
|
21.57 | -9.392 | -18.84 | 12.33 |
| Preferred Stock Dividends And Other Adjustments |
21.81%
8.578
|
7.042 | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.95%
0.059
|
126.88 | 126.85 | 126.30 | 132.58 |
| Diluted Average Shares |
97.27%
3.5693
|
130.85 | 133.93 | 126.30 | 133.93 |
| Basic Earnings Per Share |
154.55%
0.28
|
0.11 | -0.10 | -0.17 | 0.09 |
| Diluted Earnings Per Share |
145.45%
0.27
|
0.11 | -0.10 | -0.17 | 0.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
21.81%
8.578
|
7.042 | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):